Tonix Pharmaceuticals Adds Medicare Part D Coverage for TONMYA, Expands Sales Force

Tonix Pharmaceuticals announced a PBM agreement to add Medicare Part D coverage for TONMYA effective Jan 1, 2027, expanding patient access.

Key Highlights:

• Agreement adds TONMYA coverage for ~9 million Medicare Part D beneficiaries, effective January 1, 2027.
• With Medicaid coverage (~73M) and prior commercial wins, TONMYA coverage is expected to reach ~145M lives on Jan 1, 2027.
• Coverage will represent ~46% of covered U.S. lives and follows two major commercial payer agreements announced earlier.
• Tonix plans to expand its sales force by ~50 reps, reaching ~150 total reps, with deployment by mid-Q3 2026.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.